GlaxoSmithKline Pharmaceuticals submits analyst meet intimation

13 May 2025 Evaluate
Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has enclosed the presentation to be made in Investors / Analysts Call and the same is also being uploaded on the website of the Company.

The above information is a part of company’s filings submitted to BSE.



Glaxosmithkline Phar Share Price

2659.25 39.85 (1.52%)
25-Feb-2026 11:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1762.40
Dr. Reddys Lab 1317.80
Cipla 1343.50
Zydus Lifesciences 914.00
Lupin 2275.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×